New software could improve acromegaly care
NCT ID NCT04349839
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new software tool called ACRODAT that helps doctors track disease activity in people with acromegaly. The tool looks at five key factors like hormone levels, symptoms, and quality of life. Researchers compared patients whose doctors used ACRODAT to those receiving standard care over 24 months. The goal was to see if the tool leads to better treatment decisions and health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Århus University Hospital
Aarhus, Århus, 8200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Growth-Hormone blocker stay safe in everyday use? a korean study investigates
- Which intubation method works best for acromegaly patients?
- New octreotide pill faces off against current capsule in healthy volunteer study
- New drug MAR002 aims to tame acromegaly in early trial
- Scientists hunt for hidden genes behind pituitary tumors
- New study tracks Octreotide's Real-World impact on acromegaly over two years